Pancreatic Cancer Research

ResearcherHull York Medical SchoolActive in the last 2 years

Anthony Maraveyas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4176-5176; OpenAlex author ID A5060816944. Sources: ClinicalTrials.gov.

Their work

Papers
11 (first author 1, last author 2)
Trials
2 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
39
Papers, trials and grants by year

2003: 1 trial · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 2 papers · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: 1 trial · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 11

  1. Multi-protein panel in pancreatic cyst fluid for improved risk stratification for pancreatic cancer Co-author DOI 10.1101/2025.09.17.25335852↗
  2. Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PREC… Co-author DOI 10.1186/s13102-023-00722-3↗
  3. Discordant reporting of VTE in pancreatic cancer: A systematic review and meta-analysis of thromboprophylaxis versus chemotherapeutic trials. Co-author DOI 10.1111/jth.15175↗
  4. Increased dose primary thromboprophylaxis in ambulatory patients with advanced pancreatic ductal adenocarcinoma, a single centre cohort study. Co-author DOI 10.1186/s12959-020-00222-1↗
  5. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcin… Co-author DOI 10.1200/jco.20.00590↗
  6. PancREatic Cancer and Individualised Supervised Exercise (PRECISE): a feasibility trial protocol for patients with resectable pancreatic ductal adenocarcinoma Co-author DOI 10.12688/amrcopenres.12907.1↗
  7. PO-27 - Thrombin generation in pancreatic cancer and multiple myeloma with use of calibrated automated thrombography. First author DOI 10.1016/s0049-3848(16)30160-8↗
  8. PO-39 - Primary thromboprophylaxis for ambulatory patients with advanced metastatic pancreatic cancer. A practical implementation of lessons from published exp… Last author DOI 10.1016/s0049-3848(16)30172-4↗
  9. Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. Co-author DOI 10.1016/j.ejca.2011.10.017↗
  10. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phospha… Co-author DOI 10.1097/mbc.0b013e32834ad7bc↗
  11. The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis. Last author DOI 10.3390/cancers3010267↗

Trials 2

  1. Tumour Regulatory Molecules in Early Pancreatic Cancer Detection Principal investigator NCT03536793↗
  2. Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Study chair NCT00462852↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dominic O’Connor · 2 shared papers, 2020–2023 · strength 0.28
  2. Gillian Prue · 2 shared papers, 2020–2023 · strength 0.28
  3. Malcolm Brown · 2 shared papers, 2020–2023 · strength 0.28
  4. Richard Calvin Turkington · 2 shared papers, 2020–2023 · strength 0.28
  5. George Bozas · 3 shared papers, 2012–2020 · strength 0.26
  6. Dimitrios Manolis · 1 shared paper, 2025 · strength 0.22
  7. Leonid L. Nikitenko · 1 shared paper, 2025 · strength 0.22
  8. Darragh Patrick O'Brien · 1 shared paper, 2025 · strength 0.22
  9. David Kuang-Fu Chang · 1 shared paper, 2025 · strength 0.22
  10. Hemant Mahendrakumar Kocher · 1 shared paper, 2025 · strength 0.22
  11. Jeffrey Zwicker · 1 shared paper, 2021 · strength 0.17
  12. Thita Chiasakul · 1 shared paper, 2021 · strength 0.17
  13. Leigh A. Madden · 3 shared papers, 2011–2016 · strength 0.17
  14. Mufuliat Adeola Adesanya · 1 shared paper, 2016 · strength 0.10
  15. Susan Elaine Bates · 1 shared paper, 2020 · strength 0.08
  16. Andrea J. Bullock · 1 shared paper, 2020 · strength 0.08
  17. Darren S. Sigal · 1 shared paper, 2020 · strength 0.08
  18. Andrew Eugene Hendifar · 1 shared paper, 2020 · strength 0.08
  19. Fabienne Portales · 1 shared paper, 2020 · strength 0.08
  20. Do‐Youn Oh · 1 shared paper, 2020 · strength 0.08
  21. Christelle de la Fouchardière · 1 shared paper, 2020 · strength 0.08
  22. Volker Heinemann · 1 shared paper, 2020 · strength 0.08
  23. Anup Kasi · 1 shared paper, 2020 · strength 0.08
  24. Chung‐Pin Li · 1 shared paper, 2020 · strength 0.08
  25. Lei Zheng · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.